Citation: Yunchu Zhang, Tingting Li, Yuzhu Hu, Jing Chen, Yihong He, Xiang Gao, Yan Zhang. Co-delivery of doxorubicin and curcumin via cRGD-peptide modified PEG-PLA self-assembly nanomicelles for lung cancer therapy[J]. Chinese Chemical Letters, ;2022, 33(5): 2507-2511. doi: 10.1016/j.cclet.2021.11.076 shu

Co-delivery of doxorubicin and curcumin via cRGD-peptide modified PEG-PLA self-assembly nanomicelles for lung cancer therapy

    * Corresponding authors.
    E-mail addresses: xianggao@scu.edu.cn (X. Gao), zhang.yan@scu.edu.cn (Y. Zhang).
    1 These authors contributed equally to this work.
  • Received Date: 22 September 2021
    Revised Date: 17 November 2021
    Accepted Date: 26 November 2021
    Available Online: 2 December 2021

Figures(5)

  • Lung cancer is the most common malignancy in the world, with a high mortality rate. Nevertheless, therapies to act effectively against lung cancer remain elusive. So far, chemotherapy is still the frontline treatment of lung cancer. Doxorubicin (DOX) is a broad-spectrum anti-tumor drug. However, DOX often has serious side effects and causes multi-drug resistance, which greatly limits its clinical application. In this work, biodegradable methoxy poly(ethylene glycol)-poly(lactic acid) (MPEG-PLA) and cyclo(Arg-Gly-Asp-d-Phe-Lys) (cRGD) polypeptide modified PEG-PLA (cRGD-PEG-PLA) copolymers were used for the co-delivery of curcumin (CUR) and DOX (CUR-DOX/cRGD-M). The particle size of the self-assembled drug-loaded nanomicelle approximately was 27.4 nm and the zeta potential was −2.7 mV. Interestingly, CUR can enhance the uptake of DOX by Lewis lung carcinoma (LL/2) cells. The experimental results in vivo and in vitro showed that CUR-DOX/cRGD-M combination therapy could promote apoptosis of lung cancer cells, and conspicuously inhibit the tumor growth. Our data indicate that CUR-DOX/cRGD-M will be biodegradable and sustainable, which may have potential clinical application value in the treatment of lung cancer.
  • The development of solar energy conversion and storage is essential for alleviating the looming energy and environmental crisis triggered by the global population explosion and unprecedented economic growth [1-4]. However, the intermittent and diffuse nature of solar energy leave ample space to further developments. Increasingly, semiconductor photocatalysis can expand a new horizon for harnessing solar energy [5, 6]. Whereas visible light utilization rate in the solar spectrum still imposes restrictions on the available scope of transition metal oxides on Earth [7, 8]. For instance, TiO2 can only absorb approximately 5% of natural sunlight owing to its wide bandgaps (3.0 eV for rutile, 3.2 eV for anatase) [9, 10]. Nevertheless, TiO2 turns out to be a stepping stone to new photocatalysts that close the energy gap [11, 12].

    Particularly, surface-modified TiO2 with carboxyl, hydroxyl containing ligands such as ethylenediaminetetraacetic acid [13, 14], salicylic acid [15, 16], catechol [17, 18], glucose [19, 20], and cyclodextrin [21, 22] have aroused great interest on account of their high absorption of visible light and low recombination of electron-hole to achieve photocatalytic reactions efficiently. Besides, the properties of the TiO2 complexes, such as photochemical stability, optical response, and binding mode, are closely associated with the structure of ligands [23-25]. Generally, aromatic organic acids containing other functional groups like hydroxyl can form more stable surface complexes than aromatic monocarboxylic acids [26]. Nevertheless, the π-conjugation of aromatic monocarboxylic acid ligands also strongly affects the complex's stability, surface binding, and charge transfer [27, 28]. Therefore, one can embrace the concept of molecular design to select redox-active ligand based on a previously disclosed strategy [29].

    Hereby, with benzoic acid (BA) as the initial molecule, horizontally extending one or two benzene rings furnish 2-naphthoic acid (2-NA) and 2-anthracene acid (2-AA) which could be anchored onto TiO2 for the photocatalytic selective oxidation of sulfides. It is worth noting that the selective oxidation of organic sulfides has recently attracted much interest [30, 31] because the resultant sulfoxides are vital intermediates for agrochemicals, pharmaceuticals, and valuable fine chemicals [32-36]. Meanwhile, TEA, an electron transfer mediator [37], maintains the integrity of these surface ligands on TiO2. Additionally, TEA also stands out for its low boiling point in consideration of the subsequent separation and purification of sulfoxides [38]. Hence, cooperative photocatalysis of 2-AA-TiO2 with TEA in solution is established via collisional electron transfer.

    In general, the aromatic monocarboxylic acid-modified TiO2 complex is implemented by the acidolysis and exchange of the surface hydroxyl groups of TiO2 with carboxylate anions, forming the RCOO-Ti bond [26]. However, the π-conjugated system in aromatic monocarboxylic acids can greatly affect the electrostatic attraction of carboxylate anions to the titanol group, thus affecting the stability and photocatalytic activity of the ligand-modified TiO2. With BA as the initial molecule, horizontally extending the π-conjugation affords two monocarboxylic acids ligands, namely 2-NA and 2-AA (Fig. 1a). In this work, Aeroxide P25 TiO2 was adopted as the starting metal oxide to anchor BA, 2-NA, and 2-AA.

    Figure 1

    Figure 1.  (a) Horizontally extending the benzene ring of BA obtains 2-NA and 2-AA. (b) UV–vis DRS of TiO2, BA-TiO2, 2-NA-TiO2, 2-AA-TiO2. (c) Violet light-induced selective aerobic oxidation of phenyl methyl sulfide over BA-TiO2, 2-NA-TiO2, 2-AA-TiO2. Reaction conditions: CH3OH (1 mL), ligand (1.2 × 10−3 mmol), TiO2 (40 mg), TEA (0.03 mmol), phenyl methyl sulfide (0.35 mmol), aerial O2, violet LEDs (3 W × 4). (d) FTIR spectra of TiO2, 2-AA, and 2-AA-TiO2.

    Based on the ultraviolet (UV)–visible absorption spectra (Fig. S1a in Supporting information), it can be found that compared with BA, there is no absorption response to visible light completely in 2-NA, while 2-AA can harvest a band of visible light at approximately 400–420 nm. When they were assigned as redox-active ligands for the surface of TiO2, UV–visible diffuse reflectance spectra (UV–vis DRS) (Fig. 1b) show that the difference between BA-TiO2, 2-NA-TiO2, and pristine TiO2 is relatively small. Conversely, the difference between 2-AA-TiO2 and pristine TiO2 is rather obvious. Compared with TiO2, which can only absorb UV light, the response range of 2-AA-TiO2 has an obvious redshift. In addition, combining with Fig. S1b (Supporting information), Fig. 1b reveals that the light-emitting spectrum of the violet LED overlaps with the absorbance of 2-AA-TiO2. Despite the loading of these ligands, there was no change in the powder X-ray diffraction (PXRD) peaks of rutile and anatase TiO2 (Fig. S1c in Supporting information).

    Subsequently, these complexes were applied to the violet light-induced selective oxidation of phenyl methyl sulfide (Fig. 1c). It is intriguing to find a correlation between the conversions of phenyl methyl sulfide and the structure of these monocarboxylic acid ligands. With only one benzene ring, the photocatalytic activity of BA-TiO2 was almost zero under the standard conditions. With the augment of π-conjugation, the violet light-induced conversion of phenyl methyl sulfide increased from 26% over 2-NA-TiO2 to 86% over 2-AA-TiO2 for 1 h, which was attributed to the more stabilized binding of carboxyl from 2-AA with the surface hydroxyl group of TiO2. Compared with anatase TiO2 (ST-01) or rutile TiO2 with much higher specific surface areas, Aeroxide P25 TiO2 with 2-AA was the best complex photocatalyst (Table S1 in Supporting information).

    Next, the chemical states of Ti, O, and C in 2-AA-TiO2 were measured by X-ray photoelectron spectroscopy (XPS) (Fig. S2 in Supporting information). The Ti 2p1/2 (464.4 eV) and Ti 2p3/2 (458.5 eV) peaks conform to the results of Ti 2p (Fig. S2a), which are consistent with a previous investigation [37]. Meanwhile, in Fig. S2b, the XPS data of O 1s can be split into O−Ti at about 529.6 eV, O=C at about 530.9 eV, O−C at about 531.8 eV, which might be due to the presence of excessive 2-AA on the surface of the 2-AA-TiO2. According to the C 1s XPS (Fig. S2c), the carboxylate group from 2-AA successfully combined with the titanol group of TiO2 to generate the 2-AA-TiO2 complex.

    On the other hand, the formation of 2-AA-TiO2 complex was explored by Fourier-transform infrared (FTIR) spectroscopy. In Fig. 1d, the two broad peaks at 1423 cm−1 and 1403 cm−1 were attributed to the stretching vibrations of –COOTi– group. The peak (1423 cm−1) in the FTIR spectrum of 2-AA corresponded to the symmetric stretching of the hydroxy group in a carboxyl group. Therefore, it is reasonable to accept that 2-AA is successfully adsorbed on the surface of TiO2. Nevertheless, a more profound analysis is required to further determine whether the binding mode of 2-AA-TiO2 is through bidentate or monodentate via the carboxylate ligand. The FTIR spectra of pristine TiO2 and 2-AA were also presented in Fig. 1d. The primary signal peak of the carboxylic group in 2-AA are analyzed as following: 1683 cm−1 is the stretching vibration peak of C=O; the signal peaks at 1582 cm−1, 1481 cm−1, and 1461 cm−1 are assigned to C=C skeleton stretching mode; the signal peak at 1423 cm−1 is the vibration peak of O−H in carboxylate group; the strong peak at 1290 cm−1 is the stretching vibration peak of C−O [39, 40]. If the 2-AA-TiO2 possesses the monodentate mode, the FTIR spectrum of 2-AA-TiO2 should show the vibration peak of C=O. However, the actuality that the peak of C=O was vacant in the curve, revealed that 2-AA-TiO2 was more tend to the bidentate binding mode. Meanwhile, the peak of −C−O−Ti− presented in the FTIR spectrum of 2-AA-TiO2 and the slightly shifted peak position further manifested that the two oxygen atoms in the −COO− connected to the adjacent surface Ti sites respectively and formed the bridging bidentate mode. Furthermore, the FTIR spectra of BA-TiO2 and 2-NA-TiO2 are also shown in Fig. S3a (Supporting information).

    After confirming 2-AA-TiO2 complex, various control experiments were conducted for the selective aerobic oxidation of sulfide into sulfoxide. It can be found that photocatalyst synthesized in situ is more effective than the pre-prepared 2-AA-TiO2 for the selective aerobic oxidation of phenyl methyl sulfide to sulfoxide (Table S2 in Supporting information). Meanwhile, kinetic studies have shown that there is no induction time when aromatic acids modified TiO2 was in situ formed (Fig. S3b in Supporting information). Hereafter, the exploration of the effect of different wavelengths of LEDs is stated in Fig. S4a (Supporting information), proposing that the corresponding conversion is commensurate to the UV–vis DRS of 2-AA-TiO2. In Fig. S4b (Supporting information), it was found that very few sulfide were transformed into the corresponding sulfoxide with 2-AA. When 2-AA was loaded onto the surface of TiO2 to form a complex photocatalyst, the conversion of phenyl methyl sulfide was significantly improved (Fig. S4b). Synchronously, the recycling tests were implemented to testify the durability of the 2-AA-TiO2 photocatalyst (Fig. S4c in Supporting information). The recovered 2-AA-TiO2 was also reused twice with the temperate refurbishing of 2-AA, implying its superior endurance.

    Importantly, all the components of the photocatalytic system were indispensable based on the thorough control experiments. Further, the effect of the amounts of aromatic acids was explored (Fig. S5a in Supporting information). The conversion of phenyl methyl sulfide sharply increased once 2-AA was added. However, with the further increase of the dosage of 2-AA, the conversion of phenyl methyl sulfide increased slightly. With the amount of TiO2 enhanced, the yield of phenyl methyl sulfoxide advanced gradually and the selectivity of the product declined slightly (Fig. S5b in Supporting information). TEA, the electron transfer mediator, exhibited a considerable effect on the violet light-induced selective aerobic oxidation of sulfide over the 2-AA-TiO2 photocatalyst (Fig. S5c in Supporting information). Furthermore, when TEA was replaced by trimethylamine, the conversion of phenyl methyl sulfoxide decreased slightly (Table S3 in Supporting information). CH3OH, as a redox-active solvent, plays an important role in the formation of phenyl methyl sulfoxide (Table S4 in Supporting information). With the increasing power of violet LEDs, the conversion of phenyl methyl sulfide presented an increasing trend (Fig. S5d in Supporting information).

    Next, different scavengers were introduced into the system to determine the reactive oxygen species (ROS) (Fig. 2a). First, a singlet oxygen (1O2) scavenger, 1, 4-diazabicyclo[2.2.2]octane (DABCO) was added to the reaction system. The slightly reduced conversion indicated that 1O2 did not produce a decisive impact on the reaction. In contrast, when p-benzoquinone (p-BQ) was introduced to capture O2•–, the selective oxidation of sulfide was almost completely restrained, suggesting that O2•– was the pivotal ROS. Nevertheless, no reaction occurred in an atmosphere of N2, suggesting O2 is the terminal oxidant. Besides, AgNO3 completely restrained the reaction by capturing eCB. Furthermore, according to Fig. S6a (Supporting information), the flat band potential that is closely related to the conduction band (CB) potential could be linearly fitted to be −0.85 V vs. Ag/AgCl from the intercept of the x-axis, which is negative than the potential of O2/O2•– (−0.48 V vs. Ag/AgCl). According to the value of the bandgap and the CB potential, the valence band (VB) potential was calculated as +1.9 V vs. Ag/AgCl (Fig. S6b in Supporting information).

    Figure 2

    Figure 2.  (a) Quenching experiments to identify the ROS for the violet light-induced selective aerobic oxidation of phenyl methyl sulfide. Standard reaction conditions: CH3OH (1 mL), 2-AA (1.2 × 10−3 mmol), TiO2 (40 mg), TEA (0.03 mmol), phenyl methyl sulfide (0.35 mmol), aerial O2, violet LEDs (3 W × 4), 40 min. The EPR signals recoded during the violet light-induced selective aerobic oxidation of phenyl methyl sulfide over the 2-AA-TiO2 photocatalyst, (b) eCB of 2-AA-TiO2 and (c) O2•– captured by DMPO.

    To better comprehend the reaction process, electron paramagnetic resonance (EPR) experiments were then carried out. The eCB signal of 2-AA-TiO2 gradually increased with the prolongation of exposure time in the absence of O2 (Fig. 2b). Once O2 was poured, the eCB signal reduced to the initial state, indicating the relevance between O2 and eCB. The EPR signal of O2•– was then tested with 5, 5-dimethyl-1-pyrroline N-oxide (DMPO) as the capturing agent (Fig. 2c). The EPR signal of O2•– dramatically increased under violet light irradiation from 0 min to 2 min and continued to slightly increase at 4 min, suggesting that O2•– captured by DMPO was accumulated and maintained after switching off the light.

    Tentatively, a mechanism of violet light-induced selective aerobic oxidation of sulfide over 2-AA-TiO2 photocatalyst with TEA is proposed in Scheme 1. Firstly, the carboxyl group of 2-AA is in combination with the surface hydroxyl group of TiO2, constituting the 2-AA-TiO2 photocatalyst, which enables the reaction to take place at the violet light range. Next, the charge separation is generated over the surface complex by the stimulation of violet light. 2-AA would straightly infuse electrons into the CB of TiO2 to form 2-AA•+, without running into an excited state of 2-AA*. Meanwhile, O2•– is generated by the reduction of O2 at the CB of TiO2. Thirdly, the transition between TEA and TEA•+ is driven by collisional electron transfer with 2-AA•+, and the resulted TEA•+ interacts with phenyl methyl sulfide to deliver a sulfur-centered radical cation, which is pivotal to connect the TEA redox cycle and photocatalytic cycle. This connection can effectively prevent the 2-AA-TiO2 photocatalyst from being undermined by ROS. Fourthly, the sulfur-centered radical cation combines with O2•– to generate phenyl methyl persulfoxide. Ultimately, protons from CH3OH terminate phenyl methyl persulfoxide to afford phenyl methyl sulfoxide.

    Scheme 1

    Scheme 1.  A proposed mechanism of violet light-induced selective aerobic oxidation of phenyl methyl sulfide by cooperative photocatalysis of 2-AA-TiO2 with TEA.

    Then, the range of organic sulfides subjected to the photocatalytic protocol was investigated (Table 1). Phenyl methyl sulfide was oxidized to corresponding phenyl methyl sulfoxide in 88% selectivity and 85% conversion for 50 min (Table 1, entry 1). With a comparable reaction time, the sulfides containing electron-donating groups generally afforded higher conversions than that of phenyl methyl sulfide (Table 1, entries 2–4). On the contrary, conversions of sulfides containing electron-withdrawing groups were lower than that of phenyl methyl sulfide (Table 1, entries 7–12). The sulfides with an m‑methoxy group or an o‑methoxy group holding the fairly strong steric hindrance effect desired an extended reaction time (Table 1, entries 5 and 6). A similar trend was observed in sulfides containing electron-withdrawing groups (Table 1, entries 11 and 12). Therefore, affected by the steric effect, the required reaction time of the regioisomer augmented in the order of para < meta < ortho isomer. In addition, when the methyl group of phenyl methyl sulfide was replaced by an ethyl group or a phenyl group, longer reaction time was acquired (Table 1, entries 13 and 14). The selective oxidation of 2-naphthyl methyl sulfide took a longer time to reach a similar conversion (Table 1, entry 15). Moreover, the selective oxidation of aliphatic sulfides required less reaction time to achieve the considerable conversion (Table 1, entry 16) or achieved a higher conversion and selectivity with the standard reaction time (Table 1, entry 17).

    Table 1

    Table 1.  Violet light-induced selective aerobic oxidation of sulfides into sulfoxides with air by cooperative photocatalysis of 2-AA-TiO2 with TEA.a
    DownLoad: CSV

    In summary, extending the π-conjugation of aromatic acids has been adopted to construct TiO2 complex visible light photocatalysts. Intriguingly, with BA as the initial molecule, horizontally extending one or two benzene rings acquires 2-NA and 2-AA. Among three aromatic acids, 2-AA has delivered the best result over TiO2 due to the most extended π-conjugation. Importantly, TEA maintains the integrity of anchored aromatic acids and accelerates electron transfer. Conveniently, violet light-induced selective aerobic oxidation of sulfides to sulfoxides has been realized by cooperative photocatalysis of 2-AA-TiO2 with 10 mol% of TEA. This work extends the library of next-generation ligands for semiconductors to expand visible light-induced selective organic reactions.

    The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

    This work was funded by the National Natural Science Foundation of China (Nos. 22072108 and 21773173).

    Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.cclet.2021.10.068.


    1. [1]

      H. Sung, J. Ferlay, R.L. Siegel, et al., CA Cancer J. Clin. 71 (2021) 209-249.  doi: 10.3322/caac.21660

    2. [2]

      A.A. Thai, B.J. Solomon, L.V. Sequist, et al., The Lancet 398 (2021) 535-554.  doi: 10.1016/S0140-6736(21)00312-3

    3. [3]

      R.D. Neal, F. Sun, J.D. Emery, et al., BMJ 365 (2019) I1725.

    4. [4]

      F.R. Hirsch, G.V. Scagliotti, J.L. Mulshine, et al., The Lancet 389 (2016) 299.  doi: 10.1016/S0140-6736(16)30958-8

    5. [5]

      Y.W. Kong, E.C. Dreaden, S. Morandell, et al., Nat. Commun. 11 (2020) 4124.  doi: 10.1038/s41467-020-17958-z

    6. [6]

      S. Wang, G. Yu, Z. Wang, et al., Adv. Mater. 30 (2018) 1803926.  doi: 10.1002/adma.201803926

    7. [7]

      X. Jing, F. Yang, C. Shao, et al., Mol. Cancer 18 (2019) 157.  doi: 10.1186/s12943-019-1089-9

    8. [8]

      F. Roncato, F. Rruga, E. Porcu, et al., Nat. Commun. 9 (2018) 4070.  doi: 10.1038/s41467-018-06602-6

    9. [9]

      L. Zhu, W. Ma, M. Zhang, et al., Nat. Commun. 9 (2018) 1283.  doi: 10.1038/s41467-018-03546-9

    10. [10]

      K.T. Sawicki, V. Sala, L. Prever, et al., Annu. Rev. Pharmacol. Toxicol. 61 (2021) 309-332.  doi: 10.1146/annurev-pharmtox-030620-104842

    11. [11]

      J.A. Pan, H. Zhang, H. Lin, et al., Redox. Biol. 46 (2021) 102120.  doi: 10.1016/j.redox.2021.102120

    12. [12]

      J. Zhang, S. Li, F.F. An, et al., Nanoscale 7 (2015) 13503-13510.  doi: 10.1039/C5NR03259H

    13. [13]

      Y. Xi, J. Ge, M. Wang, et al., ACS Nano 14 (2020) 2904-2916.  doi: 10.1021/acsnano.9b07173

    14. [14]

      J. Lal, S.K. Gupta, D. Thavaselvam, et al., Chin. Chem. Lett. 27 (2016) 1067-1072.  doi: 10.1016/j.cclet.2016.03.032

    15. [15]

      F. Yu, Y. Tu, S. Luo, et al., Nano Lett. 21 (2021) 2216-2223.  doi: 10.1021/acs.nanolett.0c05028

    16. [16]

      P. Zhang, J. Li, M. Ghazwani, et al., Biomaterials 67 (2015) 104-114.  doi: 10.1016/j.biomaterials.2015.07.027

    17. [17]

      X. Zheng, J. Xie, X. Zhang, et al., Chin. Chem. Lett. 32 (2021) 243-257.  doi: 10.1016/j.cclet.2020.11.029

    18. [18]

      M.E. Davis, Z. Chen, D.M. Shin, et al., Nat. Rev. Drug Discov. 7 (2008) 771-782.  doi: 10.1038/nrd2614

    19. [19]

      J. Xie, Y. Lu, B. Yu, et al., Chin. Chem. Lett. 31 (2020) 1173-1177.  doi: 10.1016/j.cclet.2019.10.030

    20. [20]

      Z. Li, D. Yuan, G. Jin, et al., ACS Appl. Mater. Interfaces 8 (2016) 1842-1853.  doi: 10.1021/acsami.5b09822

    21. [21]

      S.W. Lee, M.H. Yun, S.W. Jeong, et al., J. Control. Release 155 (2011) 262-271.  doi: 10.1016/j.jconrel.2011.06.012

    22. [22]

      T. Yu, W. Nie, Z. Hong, et al., Adv. Funct. Mater. 31 (2021) 2100715.  doi: 10.1002/adfm.202100715

    23. [23]

      J. Guo, L. Gao, H. Su, et al., Biomaterials 32 (2011) 8010-8020.  doi: 10.1016/j.biomaterials.2011.07.004

    24. [24]

      M.T. Manzari, Y. Shamay, H. Kiguchi, et al., Nat. Rev. Mater. 6 (2021) 351-370.  doi: 10.1038/s41578-020-00269-6

    25. [25]

      J. Huang, X. You, P. Xin, et al., Chin. Chem. Lett. 32 (2021) 1737-1742.  doi: 10.1016/j.cclet.2020.12.006

    26. [26]

      Y. Zou, J. Wei, Y. Xia, et al., Signal Transduct. Target. Ther. 3 (2018) 32.  doi: 10.1038/s41392-018-0032-7

    27. [27]

      Y. Luo, X. Zheng, P. Yuan, et al., Bioact. Mater. 6 (2021) 4065-4072.  doi: 10.1016/j.bioactmat.2021.04.018

    28. [28]

      K. Wang, Y. Xiang, W. Pan, et al., Chin. Chem. Lett. 33 (2022) 793-797.  doi: 10.1016/j.cclet.2021.08.087

    29. [29]

      T. Sun, Y. Ding, X. Wang, et al., Nano Lett. 20 (2020) 5275-5283.  doi: 10.1021/acs.nanolett.0c01532

    30. [30]

      S. Kaihara, S. Matsumura, A.G. Mikos, et al., Nat. Protoc. 2 (2007) 2767-2771.  doi: 10.1038/nprot.2007.391

    31. [31]

      H. Cabral, Y. Matsumoto, K. Mizuno, et al., Nat. Nanotech. 6 (2011) 815-823.  doi: 10.1038/nnano.2011.166

    32. [32]

      S.D. Perrault, C. Walkey, T. Jennings, et al., Nano Lett. 9 (2009) 1909-1915.  doi: 10.1021/nl900031y

    33. [33]

      Y. Matsumoto, J.W. Nichols, K. Toh, et al., Nat. Nanotech. 11 (2016) 533-538.  doi: 10.1038/nnano.2015.342

    34. [34]

      F. Abedi, S. Davaran, M. Hekmati, et al., J. Nanobiotechnology 19 (2021) 18.  doi: 10.1186/s12951-020-00764-6

    35. [35]

      S. Dallavalle, V. Dobricic, L. Lazzarato, et al., Drug Resist. Updat. 50 (2020) 100682.  doi: 10.1016/j.drup.2020.100682

    36. [36]

      P. Chen, H.P. Huang, Y. Wang, et al., J. Exp. Clin. Cancer Res. 38 (2019) 254.  doi: 10.1186/s13046-019-1234-8

    37. [37]

      X. Dong, Y. Sun, Y. Li, et al., Small 17 (2021) 2007672.  doi: 10.1002/smll.202007672

    38. [38]

      S. Gao, Y. Wei, N. Liu, et al., J. Clin. Oncol. 34 (2016) e20048.  doi: 10.1200/JCO.2016.34.15_suppl.e20048

    39. [39]

      X. Jin, N. Liang, M. Wang, et al., Radiology 281 (2016) 958-966.  doi: 10.1148/radiol.2016150813

    1. [1]

      H. Sung, J. Ferlay, R.L. Siegel, et al., CA Cancer J. Clin. 71 (2021) 209-249.  doi: 10.3322/caac.21660

    2. [2]

      A.A. Thai, B.J. Solomon, L.V. Sequist, et al., The Lancet 398 (2021) 535-554.  doi: 10.1016/S0140-6736(21)00312-3

    3. [3]

      R.D. Neal, F. Sun, J.D. Emery, et al., BMJ 365 (2019) I1725.

    4. [4]

      F.R. Hirsch, G.V. Scagliotti, J.L. Mulshine, et al., The Lancet 389 (2016) 299.  doi: 10.1016/S0140-6736(16)30958-8

    5. [5]

      Y.W. Kong, E.C. Dreaden, S. Morandell, et al., Nat. Commun. 11 (2020) 4124.  doi: 10.1038/s41467-020-17958-z

    6. [6]

      S. Wang, G. Yu, Z. Wang, et al., Adv. Mater. 30 (2018) 1803926.  doi: 10.1002/adma.201803926

    7. [7]

      X. Jing, F. Yang, C. Shao, et al., Mol. Cancer 18 (2019) 157.  doi: 10.1186/s12943-019-1089-9

    8. [8]

      F. Roncato, F. Rruga, E. Porcu, et al., Nat. Commun. 9 (2018) 4070.  doi: 10.1038/s41467-018-06602-6

    9. [9]

      L. Zhu, W. Ma, M. Zhang, et al., Nat. Commun. 9 (2018) 1283.  doi: 10.1038/s41467-018-03546-9

    10. [10]

      K.T. Sawicki, V. Sala, L. Prever, et al., Annu. Rev. Pharmacol. Toxicol. 61 (2021) 309-332.  doi: 10.1146/annurev-pharmtox-030620-104842

    11. [11]

      J.A. Pan, H. Zhang, H. Lin, et al., Redox. Biol. 46 (2021) 102120.  doi: 10.1016/j.redox.2021.102120

    12. [12]

      J. Zhang, S. Li, F.F. An, et al., Nanoscale 7 (2015) 13503-13510.  doi: 10.1039/C5NR03259H

    13. [13]

      Y. Xi, J. Ge, M. Wang, et al., ACS Nano 14 (2020) 2904-2916.  doi: 10.1021/acsnano.9b07173

    14. [14]

      J. Lal, S.K. Gupta, D. Thavaselvam, et al., Chin. Chem. Lett. 27 (2016) 1067-1072.  doi: 10.1016/j.cclet.2016.03.032

    15. [15]

      F. Yu, Y. Tu, S. Luo, et al., Nano Lett. 21 (2021) 2216-2223.  doi: 10.1021/acs.nanolett.0c05028

    16. [16]

      P. Zhang, J. Li, M. Ghazwani, et al., Biomaterials 67 (2015) 104-114.  doi: 10.1016/j.biomaterials.2015.07.027

    17. [17]

      X. Zheng, J. Xie, X. Zhang, et al., Chin. Chem. Lett. 32 (2021) 243-257.  doi: 10.1016/j.cclet.2020.11.029

    18. [18]

      M.E. Davis, Z. Chen, D.M. Shin, et al., Nat. Rev. Drug Discov. 7 (2008) 771-782.  doi: 10.1038/nrd2614

    19. [19]

      J. Xie, Y. Lu, B. Yu, et al., Chin. Chem. Lett. 31 (2020) 1173-1177.  doi: 10.1016/j.cclet.2019.10.030

    20. [20]

      Z. Li, D. Yuan, G. Jin, et al., ACS Appl. Mater. Interfaces 8 (2016) 1842-1853.  doi: 10.1021/acsami.5b09822

    21. [21]

      S.W. Lee, M.H. Yun, S.W. Jeong, et al., J. Control. Release 155 (2011) 262-271.  doi: 10.1016/j.jconrel.2011.06.012

    22. [22]

      T. Yu, W. Nie, Z. Hong, et al., Adv. Funct. Mater. 31 (2021) 2100715.  doi: 10.1002/adfm.202100715

    23. [23]

      J. Guo, L. Gao, H. Su, et al., Biomaterials 32 (2011) 8010-8020.  doi: 10.1016/j.biomaterials.2011.07.004

    24. [24]

      M.T. Manzari, Y. Shamay, H. Kiguchi, et al., Nat. Rev. Mater. 6 (2021) 351-370.  doi: 10.1038/s41578-020-00269-6

    25. [25]

      J. Huang, X. You, P. Xin, et al., Chin. Chem. Lett. 32 (2021) 1737-1742.  doi: 10.1016/j.cclet.2020.12.006

    26. [26]

      Y. Zou, J. Wei, Y. Xia, et al., Signal Transduct. Target. Ther. 3 (2018) 32.  doi: 10.1038/s41392-018-0032-7

    27. [27]

      Y. Luo, X. Zheng, P. Yuan, et al., Bioact. Mater. 6 (2021) 4065-4072.  doi: 10.1016/j.bioactmat.2021.04.018

    28. [28]

      K. Wang, Y. Xiang, W. Pan, et al., Chin. Chem. Lett. 33 (2022) 793-797.  doi: 10.1016/j.cclet.2021.08.087

    29. [29]

      T. Sun, Y. Ding, X. Wang, et al., Nano Lett. 20 (2020) 5275-5283.  doi: 10.1021/acs.nanolett.0c01532

    30. [30]

      S. Kaihara, S. Matsumura, A.G. Mikos, et al., Nat. Protoc. 2 (2007) 2767-2771.  doi: 10.1038/nprot.2007.391

    31. [31]

      H. Cabral, Y. Matsumoto, K. Mizuno, et al., Nat. Nanotech. 6 (2011) 815-823.  doi: 10.1038/nnano.2011.166

    32. [32]

      S.D. Perrault, C. Walkey, T. Jennings, et al., Nano Lett. 9 (2009) 1909-1915.  doi: 10.1021/nl900031y

    33. [33]

      Y. Matsumoto, J.W. Nichols, K. Toh, et al., Nat. Nanotech. 11 (2016) 533-538.  doi: 10.1038/nnano.2015.342

    34. [34]

      F. Abedi, S. Davaran, M. Hekmati, et al., J. Nanobiotechnology 19 (2021) 18.  doi: 10.1186/s12951-020-00764-6

    35. [35]

      S. Dallavalle, V. Dobricic, L. Lazzarato, et al., Drug Resist. Updat. 50 (2020) 100682.  doi: 10.1016/j.drup.2020.100682

    36. [36]

      P. Chen, H.P. Huang, Y. Wang, et al., J. Exp. Clin. Cancer Res. 38 (2019) 254.  doi: 10.1186/s13046-019-1234-8

    37. [37]

      X. Dong, Y. Sun, Y. Li, et al., Small 17 (2021) 2007672.  doi: 10.1002/smll.202007672

    38. [38]

      S. Gao, Y. Wei, N. Liu, et al., J. Clin. Oncol. 34 (2016) e20048.  doi: 10.1200/JCO.2016.34.15_suppl.e20048

    39. [39]

      X. Jin, N. Liang, M. Wang, et al., Radiology 281 (2016) 958-966.  doi: 10.1148/radiol.2016150813

  • 加载中
    1. [1]

      Hongyi HuangSiyao CheWenjie ZhouYunchu ZhangWeiling ZhuoXijing YangSongping ZhengJiagang LiuXiang Gao . Apatinib potentiates doxorubicin with cRGD-functionalized pH-sensitive micelles against glioma. Chinese Chemical Letters, 2025, 36(5): 110084-. doi: 10.1016/j.cclet.2024.110084

    2. [2]

      Shuheng ZhangYuanyuan ZhangWanyu WangYuzhu HuXinchuan ChenBilan WangXiang Gao . A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy. Chinese Chemical Letters, 2024, 35(12): 109658-. doi: 10.1016/j.cclet.2024.109658

    3. [3]

      Qi HuangJun LiaoJingjing LiZhengyan GuXinkang ZhangMingxue SunWenqi MengGuanchao MaoZhipeng PeiShanshan ZhangSongling LiChuan ZhangYunqin WangJihao LiuTingbin ShuMin TaoYing LuKai XiaoQingqiang XuJincai Lu . Curcumin-loaded ceria nanoenzymes for dual-action suppression of inflammation and alleviation of oxidative damage in the treatment of acute lung injury. Chinese Chemical Letters, 2025, 36(4): 109914-. doi: 10.1016/j.cclet.2024.109914

    4. [4]

      Ying XuChengying ShenHailong YuanWei Wu . Mapping multiple phases in curcumin binary solid dispersions by fluorescence contrasting. Chinese Chemical Letters, 2024, 35(9): 109324-. doi: 10.1016/j.cclet.2023.109324

    5. [5]

      Yunjie DangYanru FengXiao ChenChaoxing HeShujie WeiDingyang LiuJinlong QiHuaxing ZhangShaokun YangZhiyun NiuBai Xiang . Development of a multi-level pH-responsive lipid nanoplatform for efficient co-delivery of siRNA and small-molecule drugs in tumor treatment. Chinese Chemical Letters, 2024, 35(12): 109660-. doi: 10.1016/j.cclet.2024.109660

    6. [6]

      Xiangqian CaoChenkai YangXiaodong ZhuMengxin ZhaoYilin YanZhengnan HuangJinming CaiJingming ZhuangShengzhou LiWei LiBing Shen . Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM. Chinese Chemical Letters, 2024, 35(8): 109199-. doi: 10.1016/j.cclet.2023.109199

    7. [7]

      Huamei ZhangJingjing LiuMingyue LiShida MaXucong ZhouAixia MengWeina HanJin Zhou . Imaging polarity changes in pneumonia and lung cancer using a lipid droplet-targeted near-infrared fluorescent probe. Chinese Chemical Letters, 2024, 35(12): 110020-. doi: 10.1016/j.cclet.2024.110020

    8. [8]

      Haiyan LuJiayue YeYiping WeiHua ZhangKonstantin ChinginVladimir FrankevichHuanwen Chen . Tracing molecular margins of lung cancer by internal extractive electrospray ionization mass spectrometry. Chinese Chemical Letters, 2025, 36(2): 110077-. doi: 10.1016/j.cclet.2024.110077

    9. [9]

      Bohao LiuXue JiangRuizhi NingHeng ZhaoYanpeng ZhangJunnan ZhangTianqing LiuDanyao QuYinhui BaoZhanchen GuoXiaoyan ZengShan GaoKun FanRunyi TaoJian JiGuangjian ZhangWeiwei Wu . Tedlar bag free: Accurate volatolomics of ⅠA stage non-small cell lung cancer come out in wash. Chinese Chemical Letters, 2025, 36(6): 110301-. doi: 10.1016/j.cclet.2024.110301

    10. [10]

      Lishan XiongXinyuan LiXiaojie LuZhendong ZhangYan ZhangWen WuChenhui Wang . Inhaled multilevel size-tunable, charge-reversible and mucus-traversing composite microspheres as trojan horse: Enhancing lung deposition and tumor penetration. Chinese Chemical Letters, 2024, 35(9): 109384-. doi: 10.1016/j.cclet.2023.109384

    11. [11]

      Jiangshan XuWeifei ZhangZhengwen CaiYong LiLong BaiShaojingya GaoQiang SunYunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620

    12. [12]

      Wenping DongMo MaJingkang LiLanlan XuDejiang GaoPinyi MaDaqian Song . Near-infrared fluorescent probe with large Stokes shift and long emission wavelength for rapid diagnosis of lung cancer via aerosol inhalation delivery. Chinese Chemical Letters, 2025, 36(5): 110147-. doi: 10.1016/j.cclet.2024.110147

    13. [13]

      Li FuZiye SuShuyang WuYanfen ChengChuan HuJinming Zhang . Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy. Chinese Chemical Letters, 2025, 36(5): 110227-. doi: 10.1016/j.cclet.2024.110227

    14. [14]

      Zhi LiShuya PanYuan TianShaowei LiuWeifeng WeiJinlin WangTianfeng ChenLing Wang . Selenium nanoparticles enhance the chemotherapeutic efficacy of pemetrexed against non-small cell lung cancer. Chinese Chemical Letters, 2024, 35(12): 110018-. doi: 10.1016/j.cclet.2024.110018

    15. [15]

      Lingjun ShaBing BoJiayu LiQi LiuYa CaoJing Zhao . Precise assessment of lung cancer-derived exosomes based on dual-labelled membrane interface. Chinese Chemical Letters, 2025, 36(4): 110109-. doi: 10.1016/j.cclet.2024.110109

    16. [16]

      Xiaoshuai WuBailei WangYichen LiXiaoxuan GuanMingjing YinWenquan LvYin ChenFei LuTao QinHuyang GaoWeiqian JinYifu HuangCuiping LiMing GaoJunyu Lu . NIR driven catalytic enhanced acute lung injury therapy by using polydopamine@Co nanozyme via scavenging ROS. Chinese Chemical Letters, 2025, 36(2): 110211-. doi: 10.1016/j.cclet.2024.110211

    17. [17]

      Qiang LiJiangbo FanHongkai MuLin ChenYongzhen YangShiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947

    18. [18]

      Wenjia WangXingyue HeXiaojie WangTiantian ZhaoOsamu MuraokaGenzoh TanabeWeijia XieTianjiao ZhouLei XingQingri JinHulin Jiang . Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (Ⅳ) prodrug delivery and enhanced colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108656-. doi: 10.1016/j.cclet.2023.108656

    19. [19]

      Boyuan LiuZixu LiuPing WangYu ZhangHaibing HeTian YinJingxin GouXing Tang . Nanomedicine-based targeting delivery systems for peritoneal cavity localized therapy: A promising treatment of ovarian cancer and its peritoneal metastasis. Chinese Chemical Letters, 2025, 36(6): 110229-. doi: 10.1016/j.cclet.2024.110229

    20. [20]

      Dandan TangNingge XuYuyang FuWei PengJinsheng WuHeng LiuFabiao Yu . Rationally designed an innovative proximity labeling near-infrared fluorogenic probe for imaging of peroxynitrite in acute lung injury. Chinese Chemical Letters, 2025, 36(5): 110082-. doi: 10.1016/j.cclet.2024.110082

Metrics
  • PDF Downloads(17)
  • Abstract views(1438)
  • HTML views(131)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Address:Zhongguancun North First Street 2,100190 Beijing, PR China Tel: +86-010-82449177-888
Powered By info@rhhz.net

/

DownLoad:  Full-Size Img  PowerPoint
Return